EUVIMEDEUVIMED entdecken
Crossref

Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management

Jiale Hou, Liying Tang, Ming Zhou, Jinhui Yang, Yongxiang Tang iD, Yi Cai, Yi Yang, Peng Liu iD, Shuo Hu iD

Molecular Pharmaceutics · 01.06.2026 · 23 (6) · 3341-3352

DOI: 10.1021/acs.molpharmaceut.5c01950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 08.05.2026. Verfasst von Jiale Hou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Optical Imaging, Glutamate Carboxypeptidase II, Positron-Emission Tomography. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Postdoctoral Program for Innovative Talents, Science and Technology Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsOptical ImagingGlutamate Carboxypeptidase IIPositron-Emission TomographyIndocyanine GreenAntigens, SurfaceRadiopharmaceuticalsMaleHumansAnimalsMiceTissue DistributionGallium RadioisotopesCell Line, TumorMice, NudeXenograft Model Antitumor Assays

Stichwörter der Autor:innen

PET imagingPSMAfluorescence imagingindocyanine greenprostate cancer

Substanzen

Glutamate Carboxypeptidase IIGallium RadioisotopesIndocyanine GreenAntigens, SurfaceFOLH1 protein, humanRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Key Laboratory of Biological Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Changsha 410008, China.
  • Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, Xiangya Hospital, Central South University, Changsha 410008, China.
  • National Clinical Research Center for Geriatric Disorders (Xiangya), Xiangya Hospital, Central South University, Changsha 410008, China.

ORCID-Profile: Yongxiang Tang, Peng Liu, Shuo Hu

Förderung

  • Natural Science Foundation of Hunan Province
  • National Postdoctoral Program for Innovative Talents
  • Science and Technology Program of Hunan Province
  • National Natural Science Foundation of China
  • Youth Science Foundation of Xiangya Hospital
  • Natural Science Foundation of Changsha City

Zitieren

APA

Hou, J., Tang, L., Zhou, M., Yang, J., Tang, Y., Cai, Y., Yang, Y., Liu, P., & Hu, S. (2026). Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management. Molecular Pharmaceutics, 23(6), 3341-3352. https://doi.org/10.1021/acs.molpharmaceut.5c01950

Vancouver

Hou J, Tang L, Zhou M, Yang J, Tang Y, Cai Y, et al. Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management. Molecular Pharmaceutics. 2026;23(6):3341-3352. doi:10.1021/acs.molpharmaceut.5c01950

BibTeX
@article{Hou2026,
  author = {Hou, Jiale and Tang, Liying and Zhou, Ming and Yang, Jinhui and Tang, Yongxiang and Cai, Yi and Yang, Yi and Liu, Peng and Hu, Shuo},
  title = {Integrating PET and Fluorescence Imaging with a Novel PSMA-ICG Conjugate for Prostate Cancer Management},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {6},
  pages = {3341--3352},
  doi = {10.1021/acs.molpharmaceut.5c01950}
}
Kostenlos starten →